1. ICD10Data
›
2. MS-DRG
›
3. The 2023 Diagnosis Related Groups dataset

DRG 839

Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc

• C91.00
  Acute lymphoblastic leukemia not having achieved remission
• C91.01
  Acute lymphoblastic leukemia, in remission
• C91.02
  Acute lymphoblastic leukemia, in relapse
• C92.00
  Acute myeloblastic leukemia, not having achieved remission
• C92.01
  Acute myeloblastic leukemia, in remission
• C92.02
  Acute myeloblastic leukemia, in relapse
• C92.40
  Acute promyelocytic leukemia, not having achieved remission
• C92.41
  Acute promyelocytic leukemia, in remission
• C92.42
  Acute promyelocytic leukemia, in relapse
• C92.50
  Acute myelomonocytic leukemia, not having achieved remission
• C92.51
  Acute myelomonocytic leukemia, in remission
• C92.52
  Acute myelomonocytic leukemia, in relapse
• C92.60
  Acute myeloid leukemia with 11q23-abnormality not having achieved remission
• C92.61
  Acute myeloid leukemia with 11q23-abnormality in remission
• C92.62
  Acute myeloid leukemia with 11q23-abnormality in relapse
• C92.A0
  Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
• C92.A1
  Acute myeloid leukemia with multilineage dysplasia, in remission
• C92.A2
  Acute myeloid leukemia with multilineage dysplasia, in relapse
• C93.00
  Acute monoblastic/monocytic leukemia, not having achieved remission
• C93.01
  Acute monoblastic/monocytic leukemia, in remission
• C93.02
  Acute monoblastic/monocytic leukemia, in relapse
• C94.00
  Acute erythroid leukemia, not having achieved remission
• C94.01
  Acute erythroid leukemia, in remission
• C94.02
  Acute erythroid leukemia, in relapse
• C95.00
  Acute leukemia of unspecified cell type not having achieved remission
• C95.01
  Acute leukemia of unspecified cell type, in remission
• C95.02
  Acute leukemia of unspecified cell type, in relapse
• Z08
  Encounter for follow-up examination after completed treatment for malignant neoplasm
• Z51.11
  Encounter for antineoplastic chemotherapy
• Z51.12
  Encounter for antineoplastic immunotherapy